Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Dr. Reddys Laboratories Stock Shows Minor Price Changes in September 2026

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Dr. Reddys Laboratories Stock Shows Minor Price Changes in September 2026

Analysed 10 Sept 2026·2 sources analysed·Business
Dr. Reddys Laboratories Stock Shows Minor Price Changes in September 2026PreviousNext

Dr. Reddys Laboratories' stock showed minor price fluctuations between September 9 and 10, 2026, with last traded prices around 1141 to 1145 INR. Market capitalization ranged from approximately 95,153 to 95,570 crore INR, with volumes varying between about 102,832 and 528,494 shares. The price-to-earnings ratio remained near 29.5, and earnings per share held steady at 38.6. These updates combine fundamental and technical data to inform investors about the stock's recent performance.

Sentiment
52%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 28/100.

Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 10 Sept 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (52/100)

Sentiment was consistent across outlets (50–55/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

economictimes broke this story on 9 Sept, 12:39 pm. Other outlets followed.

9 Sept, 12:39 pm2 sources · 16 h10 Sept, 04:23 am
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
SS Retail Launches Rs 500-Crore IPO with Price Band of Rs 403-424 Per Share
Next →
Reports Forecast AI's Impact on Economic Growth, Jobs, and Wages by 2030
economictimes9 Sept, 12:39 pm
Dr Reddys Share Price Live Updates: Dr. Reddys Stock Price History
  • 2
    economictimes10 Sept, 04:23 am
    Dr Reddys Share Price Live Updates: Dr. Reddys sees a minor price adjustment
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Dr Reddys Laboratories Limited

    Story context

    Category
    Business
    Sources analysed
    2
    Last analysed
    10 Sept 2026
    Key entities
    Reddi KingdomPrice–earnings ratioMarket capitalizationAmplitude modulation